Welcome to our dedicated page for Scholar Rock Holding SEC filings (Ticker: SRRK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking clinical milestones, cash runway, and insider sentiment at Scholar Rock shouldn’t require dissecting hundreds of biotech-specific disclosures. From complex revenue-sharing notes to detailed Phase II trial updates, Scholar Rock’s SEC filings pack dense science and accounting into every page—exactly where critical investment signals hide.
Stock Titan’s platform solves the problem. Our AI reviews each Scholar Rock annual report 10-K simplified and every Scholar Rock quarterly earnings report 10-Q filing, surfacing what matters—R&D expense trends, milestone payment schedules, and liquidity forecasts—in plain language. Need fast context on an unexpected trial update? The moment an 8-K posts, you’ll see “Scholar Rock 8-K material events explained” beside a concise summary. Curious about executive confidence levels? Real-time alerts tie each Scholar Rock Form 4 insider transactions to market dates so you can spot buying or selling before the next catalyst.
All filings are indexed and searchable:
- Form 4 feeds for Scholar Rock insider trading Form 4 transactions and Scholar Rock executive stock transactions Form 4
- 10-K, 10-Q, and 8-K documents with line-item AI commentary for quick Scholar Rock earnings report filing analysis
- DEF 14A proxy reports highlighting Scholar Rock proxy statement executive compensation
Whether you’re understanding Scholar Rock SEC documents with AI or comparing cash burn across quarters, our expert-trained algorithms and real-time EDGAR feeds give you the clarity to act decisively—no advanced biology degree required.
Scholar Rock Holding Corp (SRRK) filed a Form 144 disclosing a proposed sale of 3,353 common shares through J.P. Morgan Securities LLC on 09/22/2025 with an aggregate market value of $102,846. The shares were acquired on 09/15/2025 as a restricted stock award from the issuer and were paid for on the acquisition date. The filing reports 67,122,987 shares outstanding for the class. The notice also lists a prior sale on 07/08/2025 where Mohammed Qatanani sold 24,066 shares for gross proceeds of $828,897. The filer affirms they are not aware of undisclosed material adverse information and references Rule 10b5-1 trading plan disclosure language.
Katie Peng, a director of Scholar Rock Holding Corp (SRRK), reported sales of common stock on 09/16/2025 under a Rule 10b5-1 plan adopted 11/20/2024 to cover tax obligations from RSU vesting. The filing shows two sale events: 930 shares sold at a weighted average price of $32.4761 and 76 shares sold at a weighted average price of $33.1963, executed in multiple transactions at prices ranging $31.85–$33.73. After these sales Ms. Peng beneficially owns 33,990 shares following the first reported sale and 33,914 shares following the second, held directly and including unvested RSUs. The Form 4 was signed by an attorney-in-fact on 09/17/2025.
Insider transaction summary for Scholar Rock Holding Corp (SRRK): The reporting person, Mo Qatanani, Chief Scientific Officer, completed a sell-to-cover transaction on 09/16/2025 disposing of 3,178 shares of common stock at $33.52 per share to satisfy tax withholding arising from RSU vesting. After the transaction, the reporting person beneficially owns 112,317 shares, comprised of 3,353 issued shares and 108,964 unvested restricted stock units that vest over four years from grant dates in 2021 and 2022. The sell-to-cover was executed by a brokerage firm as required under the issuer's equity plan and was not a discretionary trade by the reporting person.
Form 144 filed for Scholar Rock Holding Corp (SRRK) reporting a proposed sale of 1,006 shares of common stock through J.P. Morgan Securities LLC on 09/16/2025. The filing shows an aggregate market value of $32,726 for the shares, with 96,127,265 shares outstanding. The securities to be sold were acquired as restricted stock units: 261 shares on 08/15/2025 and 745 shares on 09/15/2025, with payment indicated as NA. No sales by the reporting person in the prior three months are reported. The filing includes the required representation that the seller does not possess undisclosed material adverse information.
Caryn Parlavecchio, Chief Human Resources Officer of Scholar Rock Holding Corp (SRRK), reported a non-discretionary sale of common stock on 08/18/2025 to cover tax withholding for vested restricted stock units (RSUs). The Form 4 shows 2,178 shares were sold at $31.1663 per share as a mandatory "sell-to-cover" tied to RSUs that vested on 08/15/2025. After the transaction the reporting person beneficially owned 155,464 shares in total, comprising 66,222 common shares and 89,242 RSUs. The filing was signed by an attorney-in-fact on 08/19/2025.
Jeffrey S. Flier, Director of Scholar Rock Holding Corp (SRRK), executed several transactions on June 23, 2025, as part of a pre-planned Rule 10b5-1 trading plan established on February 27, 2025:
- Exercised 20,316 stock options at $21.62 per share
- Sold 17,550 shares at weighted average price of $32.16
- Sold 2,766 shares at weighted average price of $32.74
- Sold 11,136 shares at weighted average price of $33.21 (held in family trust)
Following these transactions, Flier directly owns 24,070 shares (including 16,438 common shares and 7,632 RSUs) and indirectly owns 11,136 shares through The Jeffrey S. Flier Family Trust - 2014. The exercised stock option has no remaining unvested shares. These transactions represent a significant reduction in Flier's direct holdings, suggesting potential portfolio rebalancing or profit-taking with the stock trading above $32.
FAQ
What is the current stock price of Scholar Rock Holding (SRRK)?
What is the market cap of Scholar Rock Holding (SRRK)?
